Kephera Diagnostics
Biotechnology, 1 Grant St, Framingham, , 1702, Massachusetts, United States, 1-10 Employees
Phone Number: 61********
Who is KEPHERA DIAGNOSTICS
Kephera Diagnostics, LLC is a start-up focused on development of point-of-care assays for a variety of disease conditions. Areas of focus include emerging pathogens that are of high globa...
Read More
-
Headquarters: 1 Grant St, Framingham, Massachusetts, 1702, United States
-
Date Founded: 2017
-
Employees: 1-10
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 8731
Does something look wrong? Fix it. | View contact records from KEPHERA DIAGNOSTICS
Kephera Diagnostics Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Kephera Diagnostics
Answer: Kephera Diagnostics's headquarters are located at 1 Grant St, Framingham, , 1702, Massachusetts, United States
Answer: Kephera Diagnostics's phone number is 61********
Answer: Kephera Diagnostics's official website is https://kephera.com
Answer: Kephera Diagnostics's revenue is $1 Million to $5 Million
Answer: Kephera Diagnostics's SIC: 8731
Answer: Kephera Diagnostics has 1-10 employees
Answer: Kephera Diagnostics is in Biotechnology
Answer: Kephera Diagnostics contact info: Phone number: 61******** Website: https://kephera.com
Answer: Kephera Diagnostics, LLC is a start-up focused on development of point-of-care assays for a variety of disease conditions. Areas of focus include emerging pathogens that are of high global public health significance. We work with research partners in academic and government laboratories in the U.S. and internationally to translate basic science into effective diagnostic products that address under-served medical needs. To meet this challenge, we are developing new and innovative assay technologies. Kephera has been funded under an NIH grant to develop a test for Zika virus infection that will enable diagnosis of exposed individuals, including pregnant women and others at risk of serious complications. Tests for other vector-borne viral and parasitic infections are also in the pipeline.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month